Patent · US Active

Substituted glycinamides, process for their manufacture and use thereof as medicaments

US9062034B2 · kind B2 · utility

0Cited by

3References

1Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Henning Priepke · Warthausen, DE
Georg Dahmann · Biberach an der Riß, DE
Kai Gerlach · Biberach, DE
Roland Pfau · Biberach, DE
Wolfgang Wienen · Äpfingen, DE
Annette Schuler-Metz · Ulm, DE
Sandra Handschuh · Biberach an der Riß, DE
Herbert Nar · Ochsenhausen, DE

Key dates

Filing date	Mar 5, 2013
Grant date	Jun 23, 2015
Priority date	—
Expiry date	Mar 5, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to new substituted glycinamides of general formula (I)wherein D, M, R3, R4 and R5 are defined as in the specification, the tautomers, enantiomers, diastereomers, mixtures and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.